# Ajanta Pharma Limited – FDA Inspection, Jun 23, 2023

Source: https://www.keypedia.com/records/fda_inspections/ajanta-pharma-limited/6544decf-02cf-4427-b5ce-f80dcd3dd2e4
Source feed: FDA_Inspections

> FDA inspection 1210223 of Ajanta Pharma Limited, June 23, 2023. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210223
- Company Name: Ajanta Pharma Limited
- Inspection Date: 2023-06-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1098820 - 2019-06-22
- FDA Inspection 1065151 - 2018-07-27
- FDA Inspection 1045477 - 2018-02-09
- FDA Inspection 1017983 - 2017-04-07

## Related Officers

- [Michele Gottshall](https://www.keypedia.com/people/michele-gottshall/f12dcaf7-8958-4591-88bb-f9746796b934)

Company: https://www.keypedia.com/companies/ajanta-pharma-limited/fd7fa3df-aad1-4a87-a41a-c75107fec4d6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c